The Nigerian Senate is advancing a significant bill aimed at establishing a comprehensive regulatory framework for emerging health technologies, including in vitro diagnostics, AI-assisted diagnostics, biotechnology, and genetically modified organisms (GMOs).
This legislative initiative seeks to repeal outdated laws governing food and drug regulation, replacing them with a unified statute that aligns with global best practices. Senator Suleiman Sadiq, who led the discussion, emphasized that existing regulations are antiquated and fail to address the rapid advancements in healthcare technologies and the complexities of modern supply chains.
The proposed framework expands the range of regulated products to include not just traditional food and drugs, but also processed animal feeds, vaccines, and other health-related items. It introduces essential provisions for product evaluation, post-marketing surveillance, and enhanced safety monitoring throughout a product's lifecycle. A notable addition is a legal structure for clinical trials and human intervention studies, which have been inadequately addressed in previous legislation.
Furthermore, the bill aims to adopt internationally recognized standards to bolster product quality and safety, while enhancing the enforcement capabilities of the National Agency for Food and Drug Administration and Control (NAFDAC). These reforms are expected to modernize Nigeria's regulatory landscape, improve consumer protection, and position Nigerian products more competitively in both regional and global markets.
In summary, this legislative effort represents a crucial step toward adapting Nigeria's regulatory framework to contemporary health technologies, ultimately aiming to enhance public health outcomes and support local manufacturing initiatives.